AZD8630 / AstraZeneca, Amgen 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD8630 / AstraZeneca, Amgen
Levante, NCT06529419: A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

Recruiting
2
516
Europe, Japan, US, RoW
AZD8630, Placebo, Inhaler
AstraZeneca
Asthma
03/26
04/26
NCT06795906: A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma

Not yet recruiting
1/2
24
Europe
AZD8630, Placebo, Saphira device
AstraZeneca, Parexel
Asthma
05/25
05/25
NCT05110976: A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

Completed
1
170
Europe, US
AZD8630, Placebo
AstraZeneca
Asthma
08/23
08/23
NCT06531811: A Study to Investigate the Relative Bioavailability of AZD8630 Following a Device and Formulation Transition in Healthy Participants.

Completed
1
32
US
AZD8630 (test formulation) via test inhaler, AZD8630 (reference formulation) via Monodose inhaler, Test inhaler, Monodose inhaler
AstraZeneca
Healthy Participants
10/24
10/24

Download Options